Dr. Dusan Sajic Board Certified Dermatologist

Facebook Linkedin


Dusan Sajic, MD, PhD is a Board Certified Dermatologist and Anti Aging Medicine Physician. He is an Assistant Clinical Professor (Adjunct), Medicine, Faculty of Health Sciences, McMaster University.  Dr. Sajic developed Derma Skin Institute to provide medical and cosmetic dermatology patients access to state-of-the-art technology and treatments. As a Fellow of the Royal College of Physicians and Surgeons of Canada and the American Academy of Dermatology 

Over the last two decades, Dr. Sajic has implemented industry-leading technology to pioneer new, non-invasive aesthetic skincare therapies, establishing himself as one of North America’s leading skincare innovators. Working in hand with other industry leaders, he conducts phase II – IV studies in medical and cosmetic dermatology to enhance and evaluate the safety and effectiveness of next generation skincare products. Dr Sajic Dusan has published numerous articles in high profile journals, and continues to be involved in innovative research in both medical and cosmetic dermatology


Dr. Sajic completed an Honors B.Sc. in Biology and Biochemistry followed by a Ph.D. in Molecular Immunology, Virology and Inflammation at McMaster University. He did his medical training at the University of Western Ontario followed by a residency in Dermatology at the University of Toronto.

During his studies, he was one of the few men to be awarded the Women’s Dermatologic Society Mentorship Award – an award designed to develop leadership potential in candidates who have shown early promise through exceptional activities. Furthermore, he was awarded a prestigious Principal Investigator Research Grant from the Canadian Dermatology Foundation during his final year of residency.

A highly educated and experienced dermatologist, Dr. Sajic is committed to providing individualized, effective, and evidence-based treatments with a focus on high patient satisfaction.


1. The safety and efficacy of a novel topical cosmeceutical compound combined with oral isotretinoin and laser treatments for active acne and acne scarring.Nazarali S, Pantaleon A, Sajic S, Sajic D.Dermatol Ther. 2022 Jul;35(7):e15512. doi: 10.1111/dth.15512. Epub 2022 Apr 26.

2. The use of a novel low irritancy nutraceutical compound to treat moderately severe facial acne and acne scarring.Nazarali S, Sajic D. J Cosmet Dermatol. 2022 Jan;21(1):405-406. doi: 10.1111/jocd.14084. Epub 2021 Apr .

3. Refractory Palmoplantar Pustular Psoriasis Treated With High-Dose Ustekinumab After Initial Failure.Bohdanowicz M, Sajic D. J Cutan Med Surg. 2019 Jan/Feb;23(1):102-104. doi: 10.1177/1203475418795823. Epub 2018 Aug 24.

4. Atopic dermatitis: The skin barrier and the role of ceramides. Ansiniwasis R, Sajic D, Skotnicki S.   Skin Therapy Letter. 2011;7(5)

5. A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramides. Sajic D, Asiniwasis R, Skotnicki-Grant S. Skin Therapy Lett. 2012 Jul;17(7):6-9.

6. Serpiginous mycosis fungoides in a 21-year-old man. Qiang JK, Marinas JE, Sajic D, Yeung J. JAAD Case Rep. 2015 Mar 11;1(2):82-4. doi: 10.1016/j.jdcr.2015.01.009. eCollection 

7. Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation. Boull CL, Hylwa SA, Sajic D, Tolar J, Hook KP. J Pediatr. 2016 Jun;173:242-4. doi: 10.1016/j.jpeds.2016.02.037. Epub 2016 Mar 11.

8. Buschke-Ollendorff syndrome: a novel case series and systematic review. Pope V, Dupuis L, Kannu P, Sajic D, So J, Yoon G, Lara-Corrales I. Br J Dermatol. 2016 Apr;174(4):723-9. doi: 10.1111/bjd.14366. Epub 2016 Mar 8.

9. Neutrophilic dermatoses: an update. Alavi A, Sajic D, Cerci FB, Ghazarian D, Rosenbach M, Jorizzo J. Am J Clin Dermatol. 2014 Oct;15(5):413-23. doi: 10.1007/s40257-014-0092-6.

10. Surface anatomy of the ear. Sajic D, Archibald J, Murray C. J Cutan Med Surg. 2014 Mar-Apr;18(2):137-40. doi: 10.2310/7750.2013.13057.